Tag: Psyence Group - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Psyence Group Announces Closing of Private Placement & Conclusion of Loan Agreement

Psyence Group Announces Closing of Private Placement & Conclusion of Loan Agreement

Post published:August 21, 2023
Post category:Press Release

Read more about the article Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing of Amended and Restated Business Combination Agreement

Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing of Amended and Restated Business Combination Agreement

Post published:August 2, 2023
Post category:Press Release

Read more about the article Psyence Appoints Intellectual Property Expert to Its Board of Directors

Psyence Appoints Intellectual Property Expert to Its Board of Directors

Post published:July 11, 2023
Post category:Press Release

Read more about the article Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

Post published:April 3, 2023
Post category:Press Release

Read more about the article Psyence Group Announces Cantheon Capital Private Placement

Psyence Group Announces Cantheon Capital Private Placement

Post published:March 23, 2023
Post category:Press Release

Read more about the article Psyence Partners with iNGENū for Palliative Care Clinical Trial in Australia

Psyence Partners with iNGENū for Palliative Care Clinical Trial in Australia

Post published:March 21, 2023
Post category:Press Release

Read more about the article Psyence and Eden Labs Announce Extraction and Product Development Collaboration

Psyence and Eden Labs Announce Extraction and Product Development Collaboration

Post published:January 24, 2023
Post category:Press Release

Read more about the article Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care

Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care

Post published:December 21, 2022
Post category:Press Release

Read more about the article Psyence Group Announces Closing of Second Tranche of Private Placement and Appointment of Strategic Advisor

Psyence Group Announces Closing of Second Tranche of Private Placement and Appointment of Strategic Advisor

Post published:December 14, 2022
Post category:Press Release

Read more about the article Psyence Group Completes Export of Psilocybin Mushrooms to Portugal

Psyence Group Completes Export of Psilocybin Mushrooms to Portugal

Post published:September 30, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.